drugset / Trial / NCT01112423
Safety Study of BMS-823778 in Subjects With Hypercholesterolemia
RandomizedParallel-groupTriple-blindTreatment
Summary
The purpose of this study is to assess the safety, tolerability and pharmacodynamic effects on LDL cholesterol (LDL-C)
Timeline
- Start
- 2010-06
- Primary completion
- 2010-12
- Completion
- 2010-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BMS-823778 | Small molecule | 2 mg | Oral |
| Subject | BMS-823778 | Small molecule | 10 mg | Oral |
| Subject | BMS-823778 | Small molecule | 20 mg | Oral |